Bit Digital
BTBT
Riot Platforms
RIOT
Cipher Mining
CIFR
CleanSpark
CLSK
Bitdeer Technologies
BTDR
US Stock MarketDetailed Quotes
KNSA Kiniksa Pharmaceuticals International
- 20.310
- +0.370+1.86%
Close Jan 3 16:00 ET
- 20.310
- 0.0000.00%
Post 17:22 ET
1.47BMarket Cap-169.25P/E (TTM)
20.380High19.920Low379.63KVolume19.990Open19.940Pre Close7.69MTurnover1.67%Turnover Ratio101.55P/E (Static)72.20MShares28.15052wk High3.36P/B460.78MFloat Cap16.56052wk Low--Dividend TTM22.69MShs Float32.880Historical High--Div YieldTTM2.31%Amplitude5.010Historical Low20.261Avg Price1Lot Size
About Kiniksa Pharmaceuticals International Company
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Company Profile
SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com
Company Executives
- Name
- Position
- Salary
- Sanj K. Patel
- Chief Executive Officer and Chairman of the Board
- 5.30M
- John F. Paolini, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.79M
- Eben Tessari
- Senior Vice President and Chief Operating Officer
- 1.75M
- Michael R. Megna
- Chief Accounting Officer and Group Vice President, Finance
- --
- Mark Ragosa
- Senior Vice President and Chief Financial Officer
- --
- Ross Moat
- Senior Vice President and Chief Commercial Officer
- --
- Cantey Boyd
- Director
- --
- Dr. Richard S. Levy,M.D.
- Independent Director
- 459.75K
- Kimberly J. Popovits
- Independent Director
- 362.66K
- Thomas R. Malley
- Independent Director
- 380.36K
- G. Bradley Cole
- Independent Director
- 365.36K
- Dr. Barry D. Quart,Pharm.D.
- Independent Director
- 372.55K
- Dr. Felix J. Baker,PhD
- Lead Independent Director
- 411.06K
- Tracey L. McCain, Esq.
- Independent Director
- 365.36K
- Dr. Stephen R. Biggar,M.D.,PhD
- Independent Director
- 371.96K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.